Corcept Therapeutics, Inc. (CORT)
36.48
+1.14
(+3.23%)
USD |
NASDAQ |
Feb 24, 16:00
36.20
-0.28
(-0.77%)
After-Hours: 20:00
Corcept Therapeutics Shareholders Equity (Annual) : 679.59M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Axsome Therapeutics, Inc. | 88.30M |
| United Therapeutics Corp. | 6.444B |
| Harrow, Inc. | 69.65M |
| Ultragenyx Pharmaceutical, Inc. | -80.00M |
| Amneal Pharmaceuticals, Inc. | -109.27M |